Anchor Bolt Capital LP Decreased By $1.94 Million Its Eldorado Gold New (EGO) Holding; Iradimed (IRMD) Shorts Lowered By 1.93%

November 14, 2017 - By Michael Collier

Anchor Bolt Capital Lp decreased Eldorado Gold Corp New (EGO) stake by 20.99% reported in 2017Q2 SEC filing. Anchor Bolt Capital Lp sold 970,444 shares as Eldorado Gold Corp New (EGO)’s stock declined 5.46%. The Anchor Bolt Capital Lp holds 3.65 million shares with $9.65 million value, down from 4.62 million last quarter. Eldorado Gold Corp New now has $935.52 million valuation. The stock 0.43% or $0 during the last trading session, reaching $1.17. It is down 23.79% since November 14, 2016 and is downtrending. It has underperformed by 40.49% the S&P500.

Iradimed Corporation (NASDAQ:IRMD) had a decrease of 1.93% in short interest. IRMD’s SI was 786,800 shares in November as released by FINRA. Its down 1.93% from 802,300 shares previously. With 41,500 avg volume, 19 days are for Iradimed Corporation (NASDAQ:IRMD)’s short sellers to cover IRMD’s short positions. The SI to Iradimed Corporation’s float is 17.4%. The stock decreased 0.37% or $0.05 on November 14, reaching $13.55. About 4,405 shares traded. Iradimed Corp (NASDAQ:IRMD) has declined 54.40% since November 14, 2016 and is downtrending. It has underperformed by 71.10% the S&P500.

Investors sentiment decreased to 0.56 in 2017 Q2. Its down 0.53, from 1.09 in 2017Q1. It dropped, as 14 investors sold Iradimed Corp shares while 13 reduced holdings. 6 funds opened positions while 9 raised stakes. 1.49 million shares or 16.84% less from 1.79 million shares in 2017Q1 were reported. Granite Inv Ptnrs Lc has invested 0.07% in Iradimed Corp (NASDAQ:IRMD). Envestnet Asset Mngmt stated it has 510 shares. Mondrian Investment Ltd invested 0.05% of its portfolio in Iradimed Corp (NASDAQ:IRMD). Connors Investor Incorporated, a Pennsylvania-based fund reported 33,000 shares. Morgan Stanley owns 28,728 shares or 0% of their US portfolio. Dimensional Fund Advsr Limited Partnership holds 0% or 10,885 shares. Paloma Ptnrs Mgmt reported 14,700 shares or 0% of all its holdings. Vanguard Grp holds 180,681 shares. Citigroup Incorporated has 16,082 shares for 0% of their portfolio. Bnp Paribas Arbitrage Sa stated it has 1 shares or 0% of all its holdings. Bank Of America Corp De holds 0% of its portfolio in Iradimed Corp (NASDAQ:IRMD) for 1,637 shares. Blackrock Inc invested in 0% or 42,749 shares. Royal Natl Bank Of Canada has invested 0% of its portfolio in Iradimed Corp (NASDAQ:IRMD). Deutsche Financial Bank Ag owns 4,674 shares for 0% of their portfolio. Fincl Architects owns 0% invested in Iradimed Corp (NASDAQ:IRMD) for 1 shares.

Among 2 analysts covering iRadimed (NASDAQ:IRMD), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. iRadimed had 7 analyst reports since July 30, 2015 according to SRatingsIntel. The rating was maintained by TH Capital on Monday, November 2 with “Buy”. The stock of Iradimed Corp (NASDAQ:IRMD) has “Neutral” rating given on Wednesday, October 5 by Roth Capital. The firm has “Buy” rating given on Thursday, July 30 by TH Capital. The stock of Iradimed Corp (NASDAQ:IRMD) has “Buy” rating given on Monday, July 31 by Roth Capital. Roth Capital maintained the stock with “Buy” rating in Monday, April 4 report. Roth Capital maintained the stock with “Buy” rating in Tuesday, October 31 report. The stock of Iradimed Corp (NASDAQ:IRMD) has “Buy” rating given on Monday, November 2 by Roth Capital.

IRADIMED CORPORATION develops, makes, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The company has market cap of $143.02 million. The Firm operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment. It has a 107.99 P/E ratio. The Company’s MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor, non-ferrous part and other features in order to deliver anesthesia and other IV fluids during various MRI procedures.

Since May 30, 2017, it had 0 insider purchases, and 1 sale for $38,549 activity. Another trade for 4,634 shares valued at $38,549 was made by Nardi Steven M. on Tuesday, May 30.

Analysts await Eldorado Gold Corp (USA) (NYSE:EGO) to report earnings on February, 22. EGO’s profit will be $8.00M for 29.25 P/E if the $0.01 EPS becomes a reality.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: